A MULTI-CENTRE, COMPARATIVE, DOUBLE BLIND, RANDOMISED CROSS-OVER TRIAL INVESTIGATING SINGLE DOSE PHARMACOKINETICS AND SAFETY OF TUROCTOCOG ALFA PEGOL FROM THE PIVOTAL PROCESS AND TUROCTOCOG ALFA PEGOL FROM THE COMMERCIAL PROCESS IN PATIENTS WITH SEVERE HAEMOPHILIA A: